BioSpace News Archive

Hypoxia Chamber Market – Current and Emerging Opportunity in the Applications of Cell Culture Imaging and Drug Discovery

The hypoxia chamber market has made strides on the back of the growing application of these in cell culture studies.

April 20, 2022
·
5 min read
Generic Oncology Drugs Market Is Projected to Reach a Market Value of US$ 34.8 Billion By 2028 - Comprehensive Research Report By FMI

DUBAI, United Arab Emirates, Generic oncology drugs, being able to detect and treat tumors, are utilized extensively in the healthcare industry for treating cancer.

April 20, 2022
·
5 min read
Oligonucleotide Synthesis Market: Synthesized oligonucleotides Segment to Dominate Market

Albany NY, United States: Transparency Market Research has published a new report titled, ‘Oligonucleotide Synthesis Market - Global Industry Analysis, Size, Share, Growth, Trends, and Forecast, 2019–2027’.

April 20, 2022
·
6 min read
Drug Development

Bavarian Nordic Announces Initiation of a Global Phase 3 Clinical Trial of its RSV Vaccine Candidate in Older Adults

Bavarian Nordic A/S announced the dosing of the first subject in the Phase 3 VANIR clinical trial of its investigational respiratory syncytial virus vaccine candidate, MVA-BN® RSV in older adults.

April 20, 2022
·
5 min read
Business

Invitation to presentation of BioArctic’s First Quarter Report for January - March 2022 on April 28 at 9.30 a.m. CET

BioArctic AB will publish the company’s First Quarter Report for January - March 2022 on Thursday, April 28, 2022, at 08:00 a.m. CET.

April 20, 2022
·
2 min read
New meta-analysis with Diamyd® published in scientific journal

An update of a large-scale meta-analysis supporting the efficacy of the therapeutic diabetes vaccine Diamyd® in individuals recently diagnosed with Type 1 Diabetes carrying the genetic HLA DR3-DQ2 haplotype has been published in the peer-reviewd scientific journal Diabetes, Obesity and Metabolism.

April 20, 2022
·
3 min read
Pharm Country

Indaptus Therapeutics to Present at 2nd Annual Chronic HBV Drug Development Summit

Indaptus Therapeutics, Inc. will present at the 2nd Annual Chronic HBV Drug Development Summit taking place from April 25-27, 2022 in Boston, MA.

April 20, 2022
·
4 min read
Pharm Country

VantAI Forms Research Collaboration with Boehringer Ingelheim to Identify Novel Protein Degraders

VantAI, an AI-first induced-proximity company, and Boehringer Ingelheim today announced that the two companies have entered into an early discovery research collaboration focused on degrading traditionally “undruggable” targets.

April 20, 2022
·
2 min read
Drug Development

FibroGen Announces Completion of Patient Enrollment in ZEPHYRUS-1, a Phase 3 Clinical Study of Pamrevlumab in Idiopathic Pulmonary Fibrosis

FibroGen, Inc. (NASDAQ: FGEN) today announced completion of patient enrollment for ZEPHYRUS-1, the first of two Phase 3 clinical studies of pamrevlumab in patients with idiopathic pulmonary fibrosis (IPF), a chronic, progressive, and fatal lung disease.

April 20, 2022
·
6 min read
Pharm Country

Tonix Pharmaceuticals Announces Results of Retrospective Observational Database Study In Over 50,000 Long COVID Patients

Tonix Pharmaceuticals Holding Corp. announced today the results of a retrospective observational database study in over 50,000 patients diagnosed with Long COVID.

April 20, 2022
·
8 min read